Immunology News and Research

Latest Immunology News and Research

New study reveals mechanism of inflammation in lupus

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell Medicine investigators.

15 Oct 2024

Genetics identified as key factor in gout development

A major international study has found gout is a chronic illness where genetics is a major cause, rather than lifestyle choices of the sufferer.

15 Oct 2024

New test developed to simplify the diagnosis of allergies

Researchers at the University of Bern and Bern University Hospital have developed a test to simplify the diagnosis of allergies.

15 Oct 2024

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board.

From Calluna Pharma 14 Oct 2024

Promising stool test and therapy on the horizon for endometriosis

Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful condition that affects nearly 200 million women worldwide.

12 Oct 2024

Protein discovery offers insights into bone health and potential treatments for osteoporosis

Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found.

12 Oct 2024

Gene editing enhances immunotherapy success by preventing T-cell exhaustion

Immunotherapy, using a patient's own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most.

12 Oct 2024

Placental changes may increase the risk of asthma and allergies in children

Changes in the placenta may increase the risk of children developing asthma and allergies, as shown in new research from örebro University.

8 Oct 2024

Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study.

8 Oct 2024

New platform mimics immune interactions to boost cancer treatment

Imagine a world where your own immune cells are transformed into cancer-fighting superheroes.

7 Oct 2024

UMass Amherst researcher receives $2.2 million grant to study tuberculosis response

The National Institutes of Health recently awarded $2.2 million to Alissa Rothchild, assistant professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts Amherst and an expert in tuberculosis (TB) immunology, to study the very first cells that respond to Mycobacterium tuberculosis (Mtb), the bacteria causing TB.

7 Oct 2024

Innovative immunotherapy harnesses natural killer T cells to combat solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

7 Oct 2024

Global experts gather in Brisbane for scientific meeting dedicated to influenza

More than 1,400 experts have visited Brisbane for the world's only scientific meeting dedicated to influenza.

4 Oct 2024

New insights into the role of gamma-delta T cells across 33 cancer types revealed

A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

4 Oct 2024

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

4 Oct 2024

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

Novel semi-synthetic compound shows promise against drug-resistant tuberculosis

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains.

3 Oct 2024

Researchers discover potential risk marker for cardiovascular disease in women

Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women.

3 Oct 2024

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses.

3 Oct 2024

New study could lead to a more potent treatment option for multiple sclerosis

Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath.

2 Oct 2024

Immunology News and Research

Latest Immunology News and Research

New study reveals mechanism of inflammation in lupus

Genetics identified as key factor in gout development

New test developed to simplify the diagnosis of allergies

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Promising stool test and therapy on the horizon for endometriosis

Protein discovery offers insights into bone health and potential treatments for osteoporosis

Gene editing enhances immunotherapy success by preventing T-cell exhaustion

Placental changes may increase the risk of asthma and allergies in children

Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

New platform mimics immune interactions to boost cancer treatment

UMass Amherst researcher receives $2.2 million grant to study tuberculosis response

Innovative immunotherapy harnesses natural killer T cells to combat solid tumors

Global experts gather in Brisbane for scientific meeting dedicated to influenza

New insights into the role of gamma-delta T cells across 33 cancer types revealed

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Novel semi-synthetic compound shows promise against drug-resistant tuberculosis

Researchers discover potential risk marker for cardiovascular disease in women

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

New study could lead to a more potent treatment option for multiple sclerosis

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production